View in EDS

INSURE: a pooled analysis of ixazomib-lenalidomide-dexamethasone for relapsed/refractory myeloma in routine practice.

Saved in:
Bibliographic Details
Title: INSURE: a pooled analysis of ixazomib-lenalidomide-dexamethasone for relapsed/refractory myeloma in routine practice.
Authors: Leleu X; Pôle Régional de Cancérologie, Department of Hematology, CHU La Milétrie-Poitiers, Poitiers, 86000, France., Lee HC; M.D. Anderson Cancer Center, Houston, TX 77030, USA., Zonder JA; Barbara Ann Karmanos Cancer Institute/Wayne State University School of Medicine, Detroit, MI 48201, USA., Macro M; CHU de Caen, Caen, 14000, France., Ramasamy K; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, OX3 7LE, UK., Hulin C; CHU de Bordeaux, Bordeaux, 33000, France., Silar J; Institute of Biostatistics & Analyses, Ltd, Brno, 602 00, Czech Republic., Kuhn M; Institute of Biostatistics & Analyses, Ltd, Brno, 602 00, Czech Republic., Ren K; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA 02421, USA., Bent-Ennakhil N; Takeda Pharmaceuticals International AG, Opfikon, 8152, Switzerland., Cherepanov D; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA 02421, USA., Stull DM; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA 02421, USA., Terpos E; Department of Clinical Therapeutics, National & Kapodistrian University of Athens, School of Medicine, Athens,115 27, Greece.
Source: Future oncology (London, England) [Future Oncol] 2024 May; Vol. 20 (14), pp. 935-950. Date of Electronic Publication: 2024 Jan 10.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38197267
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: INSURE: a pooled analysis of ixazomib-lenalidomide-dexamethasone for relapsed/refractory myeloma in routine practice.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Leleu+X%22">Leleu X</searchLink>; Pôle Régional de Cancérologie, Department of Hematology, CHU La Milétrie-Poitiers, Poitiers, 86000, France.<br /><searchLink fieldCode="AU" term="%22Lee+HC%22">Lee HC</searchLink>; M.D. Anderson Cancer Center, Houston, TX 77030, USA.<br /><searchLink fieldCode="AU" term="%22Zonder+JA%22">Zonder JA</searchLink>; Barbara Ann Karmanos Cancer Institute/Wayne State University School of Medicine, Detroit, MI 48201, USA.<br /><searchLink fieldCode="AU" term="%22Macro+M%22">Macro M</searchLink>; CHU de Caen, Caen, 14000, France.<br /><searchLink fieldCode="AU" term="%22Ramasamy+K%22">Ramasamy K</searchLink>; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, OX3 7LE, UK.<br /><searchLink fieldCode="AU" term="%22Hulin+C%22">Hulin C</searchLink>; CHU de Bordeaux, Bordeaux, 33000, France.<br /><searchLink fieldCode="AU" term="%22Silar+J%22">Silar J</searchLink>; Institute of Biostatistics & Analyses, Ltd, Brno, 602 00, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Kuhn+M%22">Kuhn M</searchLink>; Institute of Biostatistics & Analyses, Ltd, Brno, 602 00, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Ren+K%22">Ren K</searchLink>; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA 02421, USA.<br /><searchLink fieldCode="AU" term="%22Bent-Ennakhil+N%22">Bent-Ennakhil N</searchLink>; Takeda Pharmaceuticals International AG, Opfikon, 8152, Switzerland.<br /><searchLink fieldCode="AU" term="%22Cherepanov+D%22">Cherepanov D</searchLink>; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA 02421, USA.<br /><searchLink fieldCode="AU" term="%22Stull+DM%22">Stull DM</searchLink>; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA 02421, USA.<br /><searchLink fieldCode="AU" term="%22Terpos+E%22">Terpos E</searchLink>; Department of Clinical Therapeutics, National & Kapodistrian University of Athens, School of Medicine, Athens,115 27, Greece.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101256629%22">Future oncology (London, England)</searchLink> [Future Oncol] 2024 May; Vol. 20 (14), pp. 935-950. <i>Date of Electronic Publication: </i>2024 Jan 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101256629 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-8301 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214796694%22">14796694 </searchLink><i>NLM ISO Abbreviation: </i>Future Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38197267
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2217/fon-2023-0604
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 935
    Titles:
      – TitleFull: INSURE: a pooled analysis of ixazomib-lenalidomide-dexamethasone for relapsed/refractory myeloma in routine practice.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Leleu X
      – PersonEntity:
          Name:
            NameFull: Lee HC
      – PersonEntity:
          Name:
            NameFull: Zonder JA
      – PersonEntity:
          Name:
            NameFull: Macro M
      – PersonEntity:
          Name:
            NameFull: Ramasamy K
      – PersonEntity:
          Name:
            NameFull: Hulin C
      – PersonEntity:
          Name:
            NameFull: Silar J
      – PersonEntity:
          Name:
            NameFull: Kuhn M
      – PersonEntity:
          Name:
            NameFull: Ren K
      – PersonEntity:
          Name:
            NameFull: Bent-Ennakhil N
      – PersonEntity:
          Name:
            NameFull: Cherepanov D
      – PersonEntity:
          Name:
            NameFull: Stull DM
      – PersonEntity:
          Name:
            NameFull: Terpos E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2024 May
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1744-8301
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 14
          Titles:
            – TitleFull: Future oncology (London, England)
              Type: main
ResultId 1